70 related articles for article (PubMed ID: 1305312)
1. [Etodolac versus piroxicam in the treatment of acute lumbago. Double-blind study].
Arriagada M; Arinoviche R
Rev Med Chil; 1992 Jan; 120(1):54-8. PubMed ID: 1305312
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
Dick WC; Franchimont P; Veys E
Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
Dick WC; Bulstra S; Schardijn GH; Feenstra RM
Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
Lightfoot R
J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
[TBL] [Abstract][Full Text] [Related]
5. [Diclofenac 75mg. and 30 mg. orfenadine (Neodolpasse) versus placebo and piroxicam in postoperative analgesia after arthroscopy].
Málek J; Nedĕlová I; Lopourová M; Stefan M; Kostál R
Acta Chir Orthop Traumatol Cech; 2004; 71(2):80-3. PubMed ID: 15151094
[TBL] [Abstract][Full Text] [Related]
6. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
D'Hooghe M
Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
[TBL] [Abstract][Full Text] [Related]
8. Multicentre double-blind comparison of piroxicam and indomethacin in the treatment of lumbar diseases.
Aoki T; Kuroki Y; Kageyama T; Irimajiri S; Mizushima Y; Yamamoto K
Eur J Rheumatol Inflamm; 1983; 6(3):247-52. PubMed ID: 6239779
[TBL] [Abstract][Full Text] [Related]
9. Double-blind parallel study of piroxicam versus indomethacin in the treatment of low back pain.
Videman T; Osterman K
Ann Clin Res; 1984; 16(3):156-60. PubMed ID: 6236738
[TBL] [Abstract][Full Text] [Related]
10. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
11. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
12. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
Liang TH; Hsu PN
Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
[TBL] [Abstract][Full Text] [Related]
15. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
[TBL] [Abstract][Full Text] [Related]
16. Piroxicam fast-dissolving dosage form vs diclofenac sodium in the treatment of acute renal colic: a double-blind controlled trial.
Supervía A; Pedro-Botet J; Nogués X; Echarte JL; Mínguez S; Iglesias ML; Gelabert A
Br J Urol; 1998 Jan; 81(1):27-30. PubMed ID: 9467472
[TBL] [Abstract][Full Text] [Related]
17. An overview of the efficacy of etodolac in arthritic disorders.
Bacon PA
Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
Caldwell JR
Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
[TBL] [Abstract][Full Text] [Related]
19. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
Andelman SY
Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
[TBL] [Abstract][Full Text] [Related]
20. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
Bohl D; Gausmann H; Vorberg G; Sánchez J; García-Barbal R; Sarti JF; Harrison FJ
Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):416-9. PubMed ID: 2258250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
